Ai-hua Tan

Dr. Ai-hua Tan


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2022 in Journal of Affective Disorders
Verified
Journal Article
Open access
LPLiang Pan
Liang Pan
LLLing Li
Ling Li
HPHongye Peng
Hongye Peng
LFLianlian Fan
Lianlian Fan
JLJuan Liao
Juan Liao
YZYang Zhang
Yang Zhang
This study aimed to explore the potential effect of sleep time, pain and life satisfaction on the association between marital status and depressive symptoms. This study included 9780 individuals aged 45 years and older from the China Health and Retirement Longitudinal Study (CHARLS) in 2015. Regression analysis was used to explore the mediating effect of targeted mediators on the association between marital status and depressive symptoms. Bootstrap method was used to examine the statistical significance of the mediating effects. In the mediation model incorporating sleep time, pain and life satisfaction as mediators between marital status and depressive symptoms, the direct effect of marital status on depressive symptoms was statistically significant (p < 0.001, 95% CI = 0.699, 1.428). Approximately 39.28% (Indirect effect/Total effect) of the significant association between marital status and depressive symptoms was mediated by sleep time, pain, and life satisfaction. Limitations include non-representativeness other than rural residents and unclear cause-and-effect relationship. Those separated/divorced/widowed/never-married middle-aged and elderly individuals might be high risk population of depressive symptoms. It could be possible to relieve the depressive symptoms of these people by guaranteeing sufficient sleep, relieving pain and improving life satisfaction.

27 February 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
HLHaifei Lu
Haifei Lu
ATAi-hua Tan
Ai-hua Tan
YZYini Zhang
Yini Zhang
YCYumeng Chen
Yumeng Chen
SRSimiao Ran
Simiao Ran
PWPing Wang
Ping Wang

12 May 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
XPXun Pei
Xun Pei
JYJunjie Yao
Junjie Yao
SRSimiao Ran
Simiao Ran
HLHaifei Lu
Haifei Lu
SYShuo Yang
Shuo Yang
ATAi-hua Tan
Ai-hua Tan
Introduction: Existing evidence suggests an association between certain vitamins and metabolic syndrome (MetS), but few epidemiological studies have focused on the effects of multivitamin co-exposure on MetS. This study aims to investigate the associations of the individual or multiple water-soluble vitamins (i.e., vitamin C (VC), vitamin B9 (VB9), and vitamin B12 (VB12)) with co-exposure to MetS, as well as the dose-response relationships among them.Methods: A cross-sectional study was conducted by employing the National Health and Examination Surveys (NHANESs) 2003-2006. Multivariate-adjusted logistic regression models were used to explore the association between individual serum water-soluble vitamins and the risk of MetS and its components, including waist circumference, triglyceride, high-density lipoprotein, blood pressure, and fasting plasma glucose. Restricted cubic splines were performed to explore the dose-response relationships among them. The quantile g-computation method was adopted to explore the associations of multiple water-soluble vitamins co-exposure with MetS risk and MetS components.Results: A total of 8983 subjects were involved in the study, of whom 1443 were diagnosed with MetS. The MetS groups had a higher proportion of participants with age ≥60 years, BMI ≥30 kg/m2, and insufficient physical activity. Compared with the lowest quartile, the third (OR=0.67, 95% CI: 0.48, 0.94) and highest quartiles (OR=0.52, 95%CI: 0.35, 0.76) of VC were associated with lower MetS risk. Restricted cubic splines showed negative dose-response relationships among VC, VB9 and VB12, and MetS. Regarding MetS components, higher VC quartiles were associated with lower waist circumference, triglyceride, blood pressure, and fasting plasma glucose, while higher VC and VB9 quartiles were associated with higher high-density lipoprotein (HDL). Co-exposure to VC, VB9, and VB12 was significantly inversely associated with MetS, with ORs (95% CI) of 0.81 (0.74, 0.89) and 0.84 (0.78, 0.90) in the conditional and marginal structural models, respectively. Furthermore, we found that VC, VB9, and VB12 co-exposure were negatively associated with waist circumference and blood pressure, while VC, VB9, and VB12 co-exposure were positively associated with HDL.Conclusion: This study revealed negative associations of VC, VB9, and VB12 with MetS, while the high water-soluble vitamin co-exposure was associated with a lower MetS risk.

22 May 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
FLFu-Gui Liu
Fu-Gui Liu
ATAi-hua Tan
Ai-hua Tan
CPChao-Qun Peng
Chao-Qun Peng
YTYun-Xia Tan
Yun-Xia Tan
MYMing-Chao Yao
Ming-Chao Yao
Objective. To systematically evaluate the efficacy and safety of scalp acupuncture in the treatment of insomnia. Methods. CNKI, Wanfang database, CQVIP database, CBM, Web of Science, Cochrane Library, and PubMed were searched for the literature on the treatment of insomnia by scalp acupuncture from the establishment of the database to July 23, 2020. Two researchers independently screened the literatures and extracted the data, then evaluated the quality of the literatures, and used RevMan 5.3 software for statistical analysis. Results. A total of 21 studies including 1606 cases were included. 21 studies were included in the analysis of effective rate. The heterogeneity test showed that there was no significant heterogeneity. The fixed effect model was used, < 0.00001. The effective rate of scalp acupuncture in the treatment of insomnia was significantly higher than that of the control group. The analysis of PSQI score was finally included in 19 studies. The heterogeneity test showed that there was obvious heterogeneity. The random effect model was used, and the subgroup analysis was conducted according to the different intervention measures of the control group. The values of the drug group and the blank group were both less than 0.05, indicating that the improvement of PSQI score in the scalp acupuncture treatment of insomnia was significantly better than that in the drug group and the blank group; = 0.05 in other acupuncture groups, suggesting in scalp acupuncture treatment, there was no difference between insomnia and other acupuncture in improving the PSQI score. Six studies were included in the analysis of adverse events. The heterogeneity test showed no significant heterogeneity. The fixed effect model was used, = 0.04 < 0.05, indicating that the adverse events of scalp acupuncture in the treatment of insomnia were better than those of the control group. No publication bias analysis was conducted due to the small number of adverse events included. Publication bias was analyzed for effective rate and PSQI score. Egger’s TSTs test (effective rate = 0.001, PSQI score = 0.001) and funnel plot showed publication bias. Conclusion. Scalp acupuncture is effective and safe in the treatment of insomnia, which is worthy of clinical application. However, due to the limited number of included literature, the methodology of some studies is slightly low and the quality of literature is slightly poor. In the future, we need to design rigorous, large sample, multiple center randomized controlled study to further verify the conclusion of this study.

5 August 2022 in Medicine
Verified
Journal Article
Open access
QYQiang Yang
Qiang Yang
JLJia Liu
Jia Liu
KHKai-Lin Huang
Kai-Lin Huang
GWGuang-Yao Wang
Guang-Yao Wang
MWMi-Yuan Wang
Mi-Yuan Wang
SRSi-Miao Ran
Si-Miao Ran
Background: Vascular dementia (VaD) is a comprehensive syndrome related to the damage of cognitive function and various cerebral vascular illnesses. VaD is also generally recognized as the second most common type of dementia after Alzheimer disease, contributing to 30% of the dementia population in Asia and developing countries. The ability of donepezil hydrochloride and nimodipine had been respectively proven in improving cognitive function in vascular dementia. However, whether the combined application of both drugs contribute to better efficacy remains as a research hotspot. Studies had shown definite satisfactory result with such combination, however evidence-based evaluation of the efficacy is still lacking. Therefore, meta-analysis is employed in this study to evaluate the efficacy and safety of using donepezil hydrochloride combined with nimodipine in treating VaD to provide references for clinical treatments. The efficacy of donepezil hydrochloride combined with nimodipine on treating vascular dementia is systematically reviewed to provide evidence-based references for clinical applications. Methods: Both Chinese and English databases were searched from the start till August, 2020 for any RCT regarding the combined use of the 2 drugs in treating vascular dementia. Two investigators would later evaluate and screened out research and data based on an improved Jaded scale. Software Rev Man 5.3.0 was employed to carry out meta-analysis on clinical effificacy, mini-mental state examination (MMSE) ratings, activity of daily living (ADL) ratings, and clinical dementia scale (CDR) ratings. Results: Donepezil hydrochloride combined with nimodipine had demonstrated satisfactory efficacy on the treatment of vascular dementia. Improvements were namely spotted on MMSE scale, ADL scale, and CDR scale, with the utmost efficacy by 12 weeks after intervention. Conclusions: Donepezil hydrochloride combined with nimodipine had good efficacy in the treatment of patients with vascular dementia, mainly in terms of improving the Simple MMSE scores, the ability to use daily living scale (ADL) scores and the CDR, and the best results were obtained after 12 weeks of intervention. Such conclusion should be cautiously evaluated.

20 May 2010 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
SKS. Keysar
S. Keysar
RAR. Anderson
R. Anderson
STS. Takimoto
S. Takimoto
ATAi-hua Tan
Ai-hua Tan
IDIgor V. Deyneko
Igor V. Deyneko
AJA. Jimeno
A. Jimeno
5558 Background: A DPTM of HNSCC was established to optimally test novel therapies and the role of cancer stem cells (CSC) in relapses after therapy. This study examines the role of the Hedgehog pathway (HhP) in HNSCC and the effect of the smoothened (SMO) inhibitor IPI-926 alone and combined with the EGFR inhibitor cetuximab (Cet). Methods: Mouse models generated from implanted HNSCC surgical cases were optimized for a combination of factors (e.g. mouse strain, tumor location) yielding the most similar tumor to the parental cancer using morphologic, stroma invasion and gene expression analysis. Results: Tumor fragments from 25 cases were implanted with a 65% engraftment rate. An unbiased gene analysis comparing pathways enriched in 42 HNSCC and 14 head and neck normal tissues showed enrichment for the HhP in the cancers. IHC staining for the ligand sonic hedgehog (SHH) of a tissue array of 60 HNSCC and 20 normal tissues indicated that 65% were positive (++) or very positive (+++) and only 35% of the cancers were negative or faint (+), while 78% of normal tissues were negative for SHH. Samples from 3 DPTM and 3 cell line-derived xenografts were positive for SHH. Four DPTMs were treated in vivo with Cet, IPI-926, and the combination. IPI-926 had activity (T/C <40%) in two cases, and both Cet and the combination induced regressions in three. Whereas in all cases Cet-treated tumors re-grew 4-8 weeks post-therapy, combination- treated mice were relapse-free 3 months post-therapy. To test if Cet leads to CSC accumulation, putative CSC markers were measured by flow cytometry. CD24/44 and CD24/ALDH cells accumulated in Cet-treated tumors but decreased in combination-treated tumors. Implanted CD24/44 and CD24/ALDH positive cells generated tumors at a higher rate than negative cells despite a 100-fold cell dilution. These subgroups expressed SMO and GLI1 genes 200-fold and 700-fold higher than negative cells, respectively. Conclusions: The HhP is activated in HNSCC, with over-expression seen in the CSC subpopulation, where data suggests autologous signaling. When combined with Cet, HhP inhibition with IPI-926 diminishes CSC and prevents tumor relapse in a DPTM of HNSCC.